2021 Annual Public Meeting

Each year, the Reagan-Udall Foundation for the FDA conducts an Annual Public Meeting of its Board of Directors to share its activities in support of the U.S. Food and Drug Administration.

Engagement | Innovation | Evidence

May 12, 2021
10:00 AM – Noon (eastern)

Stakeholder engagement, innovation, and the use of real-world evidence are key components in improving America’s public health. Join us for an in-depth conversation on FDA priorities with Acting Commissioner Dr. Janet Woodcock followed by an overview of the FDA Foundation’s programs, partnerships, and impact. This free virtual meeting is open to the public, but advanced registration is required.

Image
Janet Woodcock
Janet Woodcock, MD, Commissioner of Food and Drugs (Acting), U.S. Food and Drug Administration

 

Register

Agenda

10:00 AM


 

Welcome & Opening Remarks

Ellen V. Sigal, PhD
Board Chair, Reagan-Udall Foundation for the FDA

10:05 AM
 


 

A Conversation with the Acting Commissioner of Food and Drugs

Janet Woodcock, MD
Commissioner of Food and Drugs (Acting)
U.S. Food and Drug Administration

10:25 AM


 

FDA Foundation: Engagement, Innovation, Evidence

Moderated by Susan C. Winckler, RPh, Esq.
CEO, Reagan-Udall Foundation for the FDA

11:30 AM


 

Public Comment

Open to individuals who have submitted a written request (in advance) to present a three-minute statement.

12:00 PM

Adjourn

 

Public Comments

Public comments are strictly limited to three minutes per speaker.

Comments should be submitted to Amara Shomali via email at admin@reaganudall.org by 5 PM eastern on May 10, 2021. The email should include your written comments along with your full name, affiliation, address, telephone number, and email address. You will receive a response to your request by May 11, 2021.